Histiocytic sarcoma (HS) is a very rare malignant histiocytic derivation cancer. The extranodal multisystemic HS has an aggressive clinical course and poor Disease-Free Survival (DFS) and Overall Survival (OS). There are no shared and effective therapeutic protocols; our approach aims to improve the prognosis for advanced diseases.
A novel surgical approach with peritonectomy to extranodal multisystemic histiocytic sarcoma: A case report and literature review / Barbato, Giuseppe; Tarantini, Alessandro; Serra, Francesco; Cabry, Francesca; Farinetti, Alberto; Sorrentino, Lorena; Mattioli, Anna Vittoria; Gelmini, Roberta. - In: INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS. - ISSN 2210-2612. - 59:(2019), pp. 213-216. [10.1016/j.ijscr.2019.05.027]
A novel surgical approach with peritonectomy to extranodal multisystemic histiocytic sarcoma: A case report and literature review
Barbato, Giuseppe;Tarantini, Alessandro;Serra, Francesco;Cabry, Francesca;Farinetti, Alberto;Sorrentino, Lorena;Mattioli, Anna Vittoria;Gelmini, Roberta
2019
Abstract
Histiocytic sarcoma (HS) is a very rare malignant histiocytic derivation cancer. The extranodal multisystemic HS has an aggressive clinical course and poor Disease-Free Survival (DFS) and Overall Survival (OS). There are no shared and effective therapeutic protocols; our approach aims to improve the prognosis for advanced diseases.
| File | Dimensione | Formato | |
|---|---|---|---|
|
IJSCR histicytic sarcoma HIPEC 2019.pdf
Open access
Descrizione: articolo
Tipologia:
Versione pubblicata dall'editore
Dimensione
409.17 kB
Formato
Adobe PDF
|
409.17 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris
